Management of Bacterial Vaginosis
The first-line treatment for bacterial vaginosis is oral metronidazole 500 mg twice daily for 7 days, which has a 95% cure rate and is recommended by the CDC. 1
Diagnosis Confirmation
Before initiating treatment, confirm diagnosis using Amsel's criteria (3 of 4 required):
- Homogeneous vaginal discharge
- Clue cells on microscopic examination
- Vaginal fluid pH > 4.5
- Positive whiff test (fishy odor with 10% KOH) 1
First-Line Treatment Options
All of these options are considered equally effective by the CDC:
Oral Metronidazole:
- 500 mg orally twice daily for 7 days (95% cure rate) 1
Topical Options:
- Metronidazole gel 0.75%: one full applicator (5g) intravaginally once daily for 5 days
- Clindamycin cream 2%: one full applicator (5g) intravaginally at bedtime for 7 days 1
Alternative Option:
- Tinidazole: FDA-approved for bacterial vaginosis in adult women
- 2g once daily for 2 days OR
- 1g once daily for 5 days 2
- Tinidazole: FDA-approved for bacterial vaginosis in adult women
Special Considerations
Pregnancy
- First trimester: Clindamycin cream 2% applied intravaginally at bedtime for 7 days is preferred 1
- After first trimester: Metronidazole may be safely used 1
- Alternative: Amoxicillin-clavulanic acid is a safe option during pregnancy 1
- Treatment is important as untreated BV increases risk of preterm birth, low birth weight, and chorioamnionitis 1
- Follow-up evaluation 1 month after treatment is recommended for pregnant women 1
Important Precautions
- Patients using metronidazole should avoid alcohol during treatment and for 24 hours afterward to prevent disulfiram-like reactions 1
- Patients should abstain from sexual intercourse until completing the full course of treatment 1
- Unlike STIs, routine treatment of male sex partners is not recommended for BV 1
Management of Recurrent BV
Recurrence is common, with 50-80% of women experiencing recurrence within a year of treatment 1, 3. For recurrent cases:
- Use a different treatment regimen than the initial one 1
- Extended course options:
Follow-up
- Follow-up visits are not necessary if symptoms resolve in non-pregnant women 1
- For pregnant women, follow-up evaluation 1 month after treatment completion is recommended 1
Common Pitfalls to Avoid
- Inadequate diagnosis: Ensure all other potential causes of vulvovaginitis (Trichomonas, Candida, Chlamydia, Gonorrhea, Herpes) are ruled out 2
- Poor adherence: Emphasize the importance of completing the full treatment course
- Alcohol consumption: Warn patients about disulfiram-like reactions with metronidazole 1
- Treating partners: Unlike STIs, partner treatment is not recommended and does not affect recurrence rates 1
- Single-dose treatment: While convenient, metronidazole 2g as a single dose has a lower cure rate (84%) compared to the 7-day regimen (95%) 1